RxSight(RXST)
ALISO VIEJO, CABiotechnology
Focus: RxSight is a public medical device company focused on adjustable intraocular lenses (IOLs) for cataract and aphakia correction, operating at a modest commercial scale in the high-growth ophthalmology segment.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
37-1 this month
Stable — net -1 jobs in 30d
13 added, 14 removed. Backfill posture.
Should You Work at RxSight?
AI assessmentRxSight offers a compelling growth-stage opportunity in a niche market with near-term revenue momentum, but cash constraints and product concentration warrant due diligence on runway and diversification strategy.
Why Work Here
- Public company with established revenue ($89M FY2025, +82% YoY) and commercial infrastructure, providing stability rare in early-stage biotech
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$89M
Key Products
RxSight RxLAL
Growing
Growth
Flagship proprietary IOL technology enabling post-implant light-based adjustments; commercialization phase with expanding clinical adoption.
Pipeline & Clinical Trials
Help build intelligence for RxSight
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.